OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Translational Medicine is 54. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine	258
Predicting 30-days mortality for MIMIC-III patients with sepsis-3: a machine learning approach using XGboost	238
Panaxydol attenuates ferroptosis against LPS-induced acute lung injury in mice by Keap1-Nrf2/HO-1 pathway	224
TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models Repository	204
Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients	148
Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS)	143
Precision medicine in the era of artificial intelligence: implications in chronic disease management	136
One-tube SARS-CoV-2 detection platform based on RT-RPA and CRISPR/Cas12a	136
Causal relationship between physical activity, leisure sedentary behaviors and COVID-19 risk: a Mendelian randomization study	134
The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial	129
A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine	126
Microbiota medicine: towards clinical revolution	122
SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis	122
Patient-derived xenograft (PDX) models, applications and challenges in cancer research	120
Identification of key biomarkers and immune infiltration in systemic lupus erythematosus by integrated bioinformatics analysis	112
Autoimmunity is a hallmark of post-COVID syndrome	111
Liquid biopsies: the future of cancer early detection	96
Exosomal LncRNA LINC00659 transferred from cancer-associated fibroblasts promotes colorectal cancer cell progression via miR-342-3p/ANXA2 axis	89
Heparanase and the hallmarks of cancer	86
Effects of time-restricted feeding in weight loss, metabolic syndrome and cardiovascular risk in obese women	84
Virus infection induced pulmonary fibrosis	83
Eight-hour time-restricted feeding improves endocrine and metabolic profiles in women with anovulatory polycystic ovary syndrome	80
Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis	80
Biological role of matrix stiffness in tumor growth and treatment	80
Patient-derived organoid (PDO) platforms to facilitate clinical decision making	79

Self-supervised deep learning model for COVID-19 lung CT image segmentation highlighting putative causal relationship among age, underlying disease and COVID-19	77
Natural killer cells: a promising immunotherapy for cancer	77
Machine learning for the prediction of acute kidney injury in patients with sepsis	74
Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature	74
Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications	73
Translational precision medicine: an industry perspective	73
Can the ChatGPT and other large language models with internet-connected database solve the questions and concerns of patient with prostate cancer and help democratize medical knowledge?	72
Assessing the causal association between human blood metabolites and the risk of epilepsy	72
A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma	70
Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target	68
Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling	68
The role of Exosomal miRNAs in cancer	67
Hypoxia and the phenomenon of immune exclusion	66
Application of stem cell-derived exosomes in ischemic diseases: opportunity and limitations	65
Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases	65
Study effect of probiotics and prebiotics on treatment of OVA-LPS-induced of allergic asthma inflammation and pneumonia by regulating the TLR4/NF-kB signaling pathway	65
The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome	60
Evidence of pyroptosis and ferroptosis extensively involved in autoimmune diseases at the single-cell transcriptome level	59
The global prevalence of oropharyngeal dysphagia in different populations: a systematic review and meta-analysis	59
Hypoxic exosomes orchestrate tumorigenesis: molecular mechanisms and therapeutic implications	58
LncRNA NEAT1/microRNA-129-5p/SOCS2 axis regulates liver fibrosis in alcoholic steatohepatitis	57
5-methylcytosine RNA methyltransferases and their potential roles in cancer	57
Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era	57
The roles of osteocytes in alveolar bone destruction in periodontitis	56
Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer	56
Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora	56
Causality of genetically determined metabolites on anxiety disorders: a two-sample Mendelian randomization study	55
System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma	55
Mitochondrial dysfunction: roles in skeletal muscle atrophy	54
The roles and mechanisms of hypoxia in liver fibrosis	54
GRP78 in lung cancer	54